Metafolin: Merck settles ITC probe against Macoven and Viva, but no agreement with Gnosis yet
The probe filed at the US International Trade Commission (ITC) by Merck & Cie, a Swiss subsidiary of Merck KGaA, against Macoven Pharmaceuticals, LLC, and Viva Pharmaceutical, Inc. has been settled.